Protein kinase C activators as synaptogenic and memory therapeutics

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Protein Kinase C (PKC) isoforms are vital for learning and memory processes.
• Dysfunction of PKC is implicated in various memory disorders.
• Amyloid's neurotoxicity inhibits PKC activity, contributing to cognitive decline.

Purpose of the Study:

• To investigate the role of PKC in memory and memory disorders.
• To explore the therapeutic potential of modulating PKC activity for cognitive enhancement.

Main Methods:

• Review of molecular cascades underlying memory.
• Analysis of PKC inhibition and functional deficits in learning and memory models.
• Examination of PKC's role in amyloid production and accumulation.

Main Results:

• PKC inhibition impairs learning and memory.
• Amyloid neurotoxicity negatively affects PKC activity.
• PKC deficit in animal models correlates with cognitive impairment.
• PKC isozymes regulate amyloid production and accumulation.

Conclusions:

• Restoring impaired PKC signaling can enhance memory capacity.
• Pharmacological activation of PKC, particularly isozyme-specific activators, shows promise for treating memory disorders, including Alzheimer's dementia.
• PKC activators represent a novel class of therapeutic drug candidates for memory enhancement.